Contact
searchSearch
HMP Global

COPD Topic Center

Conference Coverage
Asthma and COPD Patients With Chronic Rhinosinusitis at Higher Risk for Non-CF Bronchiectasis, Study Finds
09/19/2024
Patients with chronic rhinosinusitis face an increased risk of developing non-CF bronchiectasis, particularly if they also have asthma or COPD, according to a recent study published in The Journal of Allergy and Clinical Immunology: In...
Patients with chronic rhinosinusitis face an increased risk of developing non-CF bronchiectasis, particularly if they also have asthma or COPD, according to a recent study published in The Journal of Allergy and Clinical Immunology: In...
Patients with chronic...
09/19/2024
First Report Managed Care
Quiz
COPD and RSV Infection Incidences
07/23/2024
True or False: Patients with chronic obstructive pulmonary disease (COPD) have a lower incidence of RSV infection compared to the general population because treatments for COPD also alleviate the symptoms of RSV.
True or False: Patients with chronic obstructive pulmonary disease (COPD) have a lower incidence of RSV infection compared to the general population because treatments for COPD also alleviate the symptoms of RSV.
True or False: Patients with...
07/23/2024
First Report Managed Care
News
Comparative Effectiveness for Bronchodilator Responsiveness Testing
02/09/2024
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
Emphysema Can Be Detected During Lung Cancer Screenings
10/05/2023
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema...
10/05/2023
First Report Managed Care
Interview
Assessing the Safety of a Treatment With A Label Warning for Patients With RA, COPD
04/08/2019
Samy Suissa, PhD, professor of Epidemiology, Biostatistics and Medicine at McGill University in Montreal, discusses a label warning on a rheumatoid arthritis (RA) drug for patients with RA and COPD and he explains that the choice of biologic...
Samy Suissa, PhD, professor of Epidemiology, Biostatistics and Medicine at McGill University in Montreal, discusses a label warning on a rheumatoid arthritis (RA) drug for patients with RA and COPD and he explains that the choice of biologic...
Samy Suissa, PhD, professor of...
04/08/2019
First Report Managed Care
Newsfeed
Intensive Care Patients Benefit From Antibiotics for COPD Exacerbations
12/14/2018
Antibiotics for acute exacerbations of COPD offer strong benefit for patients in the intensive care unit but just small effects for other inpatients as well as outpatients, according to a recent systematic review. 
Antibiotics for acute exacerbations of COPD offer strong benefit for patients in the intensive care unit but just small effects for other inpatients as well as outpatients, according to a recent systematic review. 
Antibiotics for acute...
12/14/2018
First Report Managed Care
Newsfeed
Disease Management Coaching Reduces Same-Day Admissions But Not Costs
12/11/2018
A population-based disease management program significantly reduced admissions for patients with COPD and diabetes but failed to significantly cut costs for higher-risk patients as a whole, according to results from a recent study.
A population-based disease management program significantly reduced admissions for patients with COPD and diabetes but failed to significantly cut costs for higher-risk patients as a whole, according to results from a recent study.
A population-based disease...
12/11/2018
First Report Managed Care
Newsfeed
Predicting Hospitalizations: Machine Learning Better Than Existing Algorithms for COPD
12/04/2018
Machine learning techniques applied to telemonitoring datasets are better than existing algorithms at predicting COPD exacerbations requiring hospitalization and decisions to start corticosteroids, researchers found.
Machine learning techniques applied to telemonitoring datasets are better than existing algorithms at predicting COPD exacerbations requiring hospitalization and decisions to start corticosteroids, researchers found.
Machine learning techniques...
12/04/2018
First Report Managed Care
News
Long-Term Benzodiazepine Use May Increase Suicide Risk Among Veterans
10/26/2018
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the...
10/26/2018
First Report Managed Care
News
Reduced Costs, Hospitalizations for COPD With Noninvasive Ventilation
10/17/2018
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic...
10/17/2018
First Report Managed Care
News
Discharge Care Bundle Reduces Readmissions for COPD
10/16/2018
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge...
10/16/2018
First Report Managed Care

Newsfeed

News
Comparative Effectiveness for Bronchodilator Responsiveness Testing
02/09/2024
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
Emphysema Can Be Detected During Lung Cancer Screenings
10/05/2023
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema...
10/05/2023
First Report Managed Care
News
Long-Term Benzodiazepine Use May Increase Suicide Risk Among Veterans
10/26/2018
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the...
10/26/2018
First Report Managed Care
News
Reduced Costs, Hospitalizations for COPD With Noninvasive Ventilation
10/17/2018
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic...
10/17/2018
First Report Managed Care
News
Discharge Care Bundle Reduces Readmissions for COPD
10/16/2018
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge...
10/16/2018
First Report Managed Care
News
Albuminuria Linked With COPD
10/11/2018
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers,...
10/11/2018
First Report Managed Care
News
Understanding COPD Seasonality Requires Big-Picture Approach
10/04/2018
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that...
10/04/2018
First Report Managed Care
News
First-in-Class Treatment Significantly Improves COPD Symptoms
09/28/2018
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed...
09/28/2018
First Report Managed Care
News
Half of Heroin Smokers Screen Positive for COPD
09/28/2018
According to a recent study published online in CHEST, in people who smoked heroin and accessed screening services at community drug centers, about half had COPD or asthma-COPD overlap.
According to a recent study published online in CHEST, in people who smoked heroin and accessed screening services at community drug centers, about half had COPD or asthma-COPD overlap.
According to a recent study...
09/28/2018
First Report Managed Care
News
Recommended Changes for Next GOLD Guidelines Update
09/25/2018
Based on recent critiques of the current GOLD guidelines, a group of pulmonary clinicians and researchers from the Mayo Clinic have recommended several changes to the next major guideline update.
Based on recent critiques of the current GOLD guidelines, a group of pulmonary clinicians and researchers from the Mayo Clinic have recommended several changes to the next major guideline update.
Based on recent critiques of the...
09/25/2018
First Report Managed Care
News
Emerging Treatments Improve Outcomes for Patients With Relapsed/Refractory Follicular Lymphoma
03/21/2025
Recent advancements in bispecific antibodies (BsAbs) and chimeric antigen receptor (CAR) T-cell therapies are revolutionizing the treatment landscape for patients with relapsed or refractory follicular lymphoma (RR-FL), offering new hope for...
Recent advancements in bispecific antibodies (BsAbs) and chimeric antigen receptor (CAR) T-cell therapies are revolutionizing the treatment landscape for patients with relapsed or refractory follicular lymphoma (RR-FL), offering new hope for...
Recent advancements in...
03/21/2025
First Report Managed Care
News
Biosimilars Gain Market Traction but Adoption Varies by Demographics and Other Factors
03/18/2025
Biosimilars are gaining market share and reducing drug costs, but patient adoption varies based on demographics, care settings, and payer policies.
Biosimilars are gaining market share and reducing drug costs, but patient adoption varies based on demographics, care settings, and payer policies.
Biosimilars are gaining market...
03/18/2025
First Report Managed Care
News
Patients With Vitiligo Face Elevated Risk of Cardiovascular Disease, Study Finds
03/14/2025
Individuals with vitiligo have an increased risk of major cardiovascular events, including stroke and venous thromboembolism, according to researchers.
Individuals with vitiligo have an increased risk of major cardiovascular events, including stroke and venous thromboembolism, according to researchers.
Individuals with vitiligo have...
03/14/2025
First Report Managed Care
News
Unlocking Cost-Efficiency and Access With Biosimilar Bevacizumab in Medicare
03/13/2025
New research shows significant cost savings and potential for expanded access to biosimilar bevacizumab in Medicare for patients with metastatic colorectal and non-small cell lung cancer.
New research shows significant cost savings and potential for expanded access to biosimilar bevacizumab in Medicare for patients with metastatic colorectal and non-small cell lung cancer.
New research shows significant...
03/13/2025
First Report Managed Care
News
Study Finds Limited Benefit of Common MS Fatigue Medications
03/12/2025
Commonly used medications for multiple sclerosis-related fatigue offer minimal clinical benefit and are more likely to cause treatment discontinuation due to side effects, according to a systematic review and meta-analysis published in...
Commonly used medications for multiple sclerosis-related fatigue offer minimal clinical benefit and are more likely to cause treatment discontinuation due to side effects, according to a systematic review and meta-analysis published in...
Commonly used medications for...
03/12/2025
First Report Managed Care
News
Bridging the Gap: Mental Health Support for Individuals With Skin Conditions
03/07/2025
A recently published review explores the impact of skin diseases on mental health, emphasizing the need for culturally sensitive approaches and digital health technologies to support individuals with skin conditions.
A recently published review explores the impact of skin diseases on mental health, emphasizing the need for culturally sensitive approaches and digital health technologies to support individuals with skin conditions.
A recently published review...
03/07/2025
First Report Managed Care
News
Bispecific Antibody Therapy Achieves Sustained Remissions in Follicular Lymphoma
03/06/2025
A 3-year follow-up of a phase 1/2 study confirms that mosunetuzumab, a CD20×CD3 bispecific antibody, provides durable remissions, high response rates, and a favorable safety profile in relapsed or refractory follicular lymphoma, reinforcing...
A 3-year follow-up of a phase 1/2 study confirms that mosunetuzumab, a CD20×CD3 bispecific antibody, provides durable remissions, high response rates, and a favorable safety profile in relapsed or refractory follicular lymphoma, reinforcing...
A 3-year follow-up of a phase...
03/06/2025
First Report Managed Care
News
Shifting Trends in Trastuzumab Utilization As Biosimilar Adoption Increases
03/05/2025
The use of trastuzumab for treating breast and other cancers has declined as trastuzumab biosimilars gain widespread adoption in the US.
The use of trastuzumab for treating breast and other cancers has declined as trastuzumab biosimilars gain widespread adoption in the US.
The use of trastuzumab for...
03/05/2025
First Report Managed Care
News
Revolutionizing Rural Medicine With AI-Powered Mobile Clinics
02/21/2025
A new initiative led by the University of Michigan is using artificial intelligence (AI)-driven mobile clinics to bring expert healthcare to underserved rural populations.
A new initiative led by the University of Michigan is using artificial intelligence (AI)-driven mobile clinics to bring expert healthcare to underserved rural populations.
A new initiative led by the...
02/21/2025
First Report Managed Care
News
Biosimilar Adalimumab Adoption Could Yield Millions in Cost Savings, Study Finds
02/20/2025
A financial analysis reveals that adopting biosimilar adalimumab in commercial health plans could lead to substantial cost savings with minimal medical cost implications.
A financial analysis reveals that adopting biosimilar adalimumab in commercial health plans could lead to substantial cost savings with minimal medical cost implications.
A financial analysis reveals...
02/20/2025
First Report Managed Care

Insights

Interview
Assessing the Safety of a Treatment With A Label Warning for Patients With RA, COPD
04/08/2019
Samy Suissa, PhD, professor of Epidemiology, Biostatistics and Medicine at McGill University in Montreal, discusses a label warning on a rheumatoid arthritis (RA) drug for patients with RA and COPD and he explains that the choice of biologic...
Samy Suissa, PhD, professor of Epidemiology, Biostatistics and Medicine at McGill University in Montreal, discusses a label warning on a rheumatoid arthritis (RA) drug for patients with RA and COPD and he explains that the choice of biologic...
Samy Suissa, PhD, professor of...
04/08/2019
First Report Managed Care

Behind the Bill

Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care
Behind the Bill
Medicare Drug Negotiations 2.0: New Administration, Same Mission?
01/22/2025
Last week brought 2 major developments in health care policy: President Trump's inauguration and the Centers for Medicare and Medicaid Services’ (CMS) announcement of 15 additional drugs selected for Medicare price negotiations. While these...
Last week brought 2 major developments in health care policy: President Trump's inauguration and the Centers for Medicare and Medicaid Services’ (CMS) announcement of 15 additional drugs selected for Medicare price negotiations. While these...
Last week brought 2 major...
01/22/2025
First Report Managed Care
Behind the Bill
The First 100 Days: Health Care's Critical Deadlines in 2025
01/15/2025
The 119th Congress faces immediate health care deadlines amid significant leadership transitions. While much attention focuses on high-profile nominations like Dr Oz for Centers for Medicare and Medicaid Services (CMS) Administrator and...
The 119th Congress faces immediate health care deadlines amid significant leadership transitions. While much attention focuses on high-profile nominations like Dr Oz for Centers for Medicare and Medicaid Services (CMS) Administrator and...
The 119th Congress faces...
01/15/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Impact of Multi-Drug Resistant Bacterial Infections on Patients With Bronchiectasis
09/27/2024
A study published in the Annals of Clinical Microbiology and Antimicrobials explores the impact of multidrug-resistant (MDR) bacterial infections on the clinical outcomes of adult patients with bronchiectasis, finding a significant increase...
A study published in the Annals of Clinical Microbiology and Antimicrobials explores the impact of multidrug-resistant (MDR) bacterial infections on the clinical outcomes of adult patients with bronchiectasis, finding a significant increase...
A study published in the Annals...
09/27/2024
First Report Managed Care
Conference Coverage
Successes and Challenges Ahead: Navigating Changes in IRA and Medicare Part D
10/18/2024
Explore the implications of the CY 2025 Medicare Part D Redesign and the Inflation Reduction Act with AMCP Nexus 2024 session speakers, addressing successes and challenges faced by stakeholders as they prepare for significant changes ahead.
Explore the implications of the CY 2025 Medicare Part D Redesign and the Inflation Reduction Act with AMCP Nexus 2024 session speakers, addressing successes and challenges faced by stakeholders as they prepare for significant changes ahead.
Explore the implications of the...
10/18/2024
First Report Managed Care
News
Three-Year Drug Survival 80% for Ixekizumab in Real-World Patients With Plaque Psoriasis
04/18/2023
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug...
04/18/2023
First Report Managed Care
News
Biosimilar Rituximab Compared to Originator Rituximab for Treatment of Patients With DLBCL
05/12/2023
According to findings from a phase 3 trial, biosimilar rituximab had comparable efficacy and safety to originator rituximab among patients with diffuse large B-cell lymphoma.
According to findings from a phase 3 trial, biosimilar rituximab had comparable efficacy and safety to originator rituximab among patients with diffuse large B-cell lymphoma.
According to findings from a...
05/12/2023
Oncology
Conference Coverage
Treating Advanced Melanoma With Fianlimab and Cemiplimab
06/01/2023
Researchers at ASCO 2023 presented data on the outcomes of treating patients with advanced melanoma, including patients who previously received adjuvant therapy, with fianlimab and cemiplimab.
Researchers at ASCO 2023 presented data on the outcomes of treating patients with advanced melanoma, including patients who previously received adjuvant therapy, with fianlimab and cemiplimab.
Researchers at ASCO 2023...
06/01/2023
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use